Work

Supplementary Figure S2 from Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non–Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure 2. Baseline (high vs. low) frequency of peripheral blood (PB) CX3CR1+ CD8+ T cells does not associate with response and prognosis in NSCLC patients undergoing chemo-immunotherapy. Related to Fig. 1 Overall response rate (ORR), progression free survival (PFS), and overall survival (OS) of patients with high and low pre-treatment frequency of the CX3CR1+ subset in PB CD8+ T cells at various cut-off points. P values were calculated by a log-rank (Mantel-Cox) test.

DOI: 10.1158/2767-9764.22358076.v1

Authors: Eihab Abdelfatah, Mark D. Long, Ryutaro Kajihara, Takaaki Oba, Takayoshi Yamauchi, Hongbin Chen, Joy Sarkar, Kristopher Attwood, Junko Matsuzaki, Brahm H. Segal, Grace K. Dy, Fumito Ito

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361197716

Cites:

Cited by:

Related to: 10